Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PMV Pharmaceuticals, Inc. Director's Dealing 2024

Oct 3, 2024

34350_dirs_2024-10-03_76e376f7-b7d3-4c75-9fe0-b8be668ee99c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PMV Pharmaceuticals, Inc. (PMVP)
CIK: 0001699382
Period of Report: 2024-08-13

Reporting Person: Carulli Michael (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-08-13 Employee Stock Option (right to buy) $28.33 D 13605 Disposed 2031-05-12 Common Stock (13605) Direct
2024-08-13 Employee Stock Option (right to buy) $16.29 D 27200 Disposed 2032-02-10 Common Stock (27200) Direct
2024-08-13 Employee Stock Option (right to buy) $1.48 A 40805 Acquired 2034-08-13 Common Stock (40805) Direct
2024-08-13 Employee Stock Option (right to buy) $5.70 D 75000 Disposed 2033-05-12 Common Stock (75000) Direct
2024-08-13 Employee Stock Option (right to buy) $1.48 A 75000 Acquired 2034-08-13 Common Stock (75000) Direct

Footnotes

F1: Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2021.

F2: On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 13,605 shares of PMV common stock granted to the reporting person on May 12, 2021. In exchange, the reporting person received a replacement option, for 13,605 shares, having an exercise price of $1.48 per share.

F3: Shares subject to the option vest in 48 equal monthly installments beginning on March 10, 2022.

F4: On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 27,200 shares of PMV common stock granted to the reporting person on February 10, 2022. In exchange, the reporting person received a replacement option, for 27,200 shares, having an exercise price of $1.48 per share.

F5: One-third of the shares subject to the option vest on August 13, 2025 and 1/36th vest monthly thereafter.

F6: Shares subject to the option vest in 48 equal monthly installments beginning on June 12. 2023.

F7: On August 13, 2024, the issuer cancelled, pursuant to the issuer's option exchange program, an option for 75,000 shares of PMV common stock granted to the reporting person on May 12, 2023. In exchange, the reporting person received a replacement option, for 75,000 shares, having an exercise price of $1.48 per share.

F8: One-fourth of the shares subject to the option vest on August 13, 2025 and 1/48th vest monthly thereafter.